Nephrotic syndrome, defined as the presence of proteinuria (>3.5 g/24 hours), hypoalbuminaemia (<30 g/L), and peripheral oedema, is a relatively rare but important manifestation of kidney disease.
Despite the presence of heavy proteinuria and lipiduria in patients with nephrotic syndrome, the urine contains few cells or casts. This differs from nephritic syndrome, which is typically defined as the presence of acute kidney injury (renal dysfunction), hypertension, and an active urinary sediment (red cells and red cell casts).
In the US, annual incidence of nephrotic syndrome among children is reported to be 2-7 cases per 100,000.[12]Londeree J, McCracken CE, Greenbaum LA, et al. Estimation of childhood nephrotic syndrome incidence: data from the atlanta metropolitan statistical area and meta-analysis of worldwide cases. J Nephrol. 2022 Mar;35(2):575-83.
http://www.ncbi.nlm.nih.gov/pubmed/34213762?tool=bestpractice.com
[13]van Husen M, Kemper MJ. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol. 2011 Jun;26(6):881-92.
http://www.ncbi.nlm.nih.gov/pubmed/21229269?tool=bestpractice.com
[14]Zhang S, Audard V, Fan Q, et al. Immunopathogenesis of idiopathic nephrotic syndrome. Contrib Nephrol. 2011;169:94-106.
http://www.ncbi.nlm.nih.gov/pubmed/21252513?tool=bestpractice.com
[15]Gbadegesin R, Lavin P, Foreman J, et al. Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatr Nephrol. 2011 Jul;26(7):1001-15.
http://www.ncbi.nlm.nih.gov/pubmed/21110043?tool=bestpractice.com
[16]Elie V, Fakhoury M, Deschênes G, et al. Physiopathology of
idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic
perspectives. Pediatr Nephrol. 2012 Aug;27(8):1249-56.
http://www.ncbi.nlm.nih.gov/pubmed/21710250?tool=bestpractice.com
[17]El Bakkali L, Rodrigues Pereira R, Kuik DJ, et al. Nephrotic syndrome in the Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol. 2011 Aug;26(8):1241-6.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119807
http://www.ncbi.nlm.nih.gov/pubmed/21533870?tool=bestpractice.com
In adults, nephrotic syndrome incidence is approximately 3-4 cases per 100,000 each year.[18]Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ. 2008 May 24;336(7654):1185-9.
http://www.bmj.com/content/336/7654/1185.long
http://www.ncbi.nlm.nih.gov/pubmed/18497417?tool=bestpractice.com
[19]Vestergaard SV, Birn H, Jensen SK, et al. Twenty-four-year trends in incidence and mortality of nephrotic syndrome: a population-based cohort study. Epidemiology. 2023 May 1;34(3):411-20.
http://www.ncbi.nlm.nih.gov/pubmed/36730008?tool=bestpractice.com
Aetiology: children
The most common cause of nephrotic syndrome in young children is minimal change disease (MCD). Renal biopsy is not usually performed if children with MCD are steroid-sensitive (steroid-sensitive nephrotic syndrome).[20]Trautmann A, Boyer O, Hodson E, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2023 Mar;38(3):877-919.
https://link.springer.com/article/10.1007/s00467-022-05739-3
http://www.ncbi.nlm.nih.gov/pubmed/36269406?tool=bestpractice.com
Children with steroid-resistant nephrotic syndrome (SRNS) undergo renal biopsy, with the pathology most likely to be focal segmental glomerulosclerosis (FSGS). In older children/adolescents, the incidence of MCD starts to decrease, and other causes of nephrotic syndrome become more common.
Aetiology: adults
There are many possible differential diagnoses in adults presenting with nephrotic syndrome. A renal biopsy is necessary in the vast majority of cases to obtain the diagnosis. Data from the US and Europe suggest that FSGS is a common cause of nephrotic syndrome in adults; FSGS incidence is similar to, or greater than, membranous nephropathy in some studies.[21]Haas M, Meehan SM, Karrison TG, et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis. 1997 Nov;30(5):621-31.
http://www.ncbi.nlm.nih.gov/pubmed/9370176?tool=bestpractice.com
[22]Braden GL, Mulhern JG, O'Shea MH, et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis. 2000 May;35(5):878-83.
http://www.ncbi.nlm.nih.gov/pubmed/10793022?tool=bestpractice.com
[23]Kolb A, Gallacher PJ, Campbell J, et al. A national registry study of patient and renal survival in adult nephrotic syndrome. Kidney Int Rep. 2021 Feb;6(2):449-59.
https://www.kireports.org/article/S2468-0249(20)31704-6/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33615070?tool=bestpractice.com
In one series of renal biopsies in adults with unexplained nephrotic syndrome, the relative aetiological frequencies were: 35% FSGS; 33% membranous nephropathy; 15% MCD; 9% IgA nephropathy; 4% amyloidosis; and 4% other.[21]Haas M, Meehan SM, Karrison TG, et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis. 1997 Nov;30(5):621-31.
http://www.ncbi.nlm.nih.gov/pubmed/9370176?tool=bestpractice.com
In older people, membranous nephropathy is the most common cause of nephrotic syndrome.[23]Kolb A, Gallacher PJ, Campbell J, et al. A national registry study of patient and renal survival in adult nephrotic syndrome. Kidney Int Rep. 2021 Feb;6(2):449-59.
https://www.kireports.org/article/S2468-0249(20)31704-6/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33615070?tool=bestpractice.com
[24]Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol. 2003 Mar;23(2):172-82.
http://www.ncbi.nlm.nih.gov/pubmed/12704577?tool=bestpractice.com
[25]Deegens JK, Wetzels JF. Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs Aging. 2007;24(9):717-32.
http://www.ncbi.nlm.nih.gov/pubmed/17727303?tool=bestpractice.com
[26]Jönsson A, Hellmark T, Segelmark M, et al. Causes of nephrotic syndrome in Sweden: the relevance of clinical presentation and demographics. Front Nephrol. 2023 Mar 17:3:1026864.
https://www.frontiersin.org/journals/nephrology/articles/10.3389/fneph.2023.1026864/full
http://www.ncbi.nlm.nih.gov/pubmed/37675382?tool=bestpractice.com
Diabetic nephropathy is the most common cause of nephrotic syndrome in adults with a history of long-standing diabetes.
Many of the diseases that cause nephrotic syndrome in adults (e.g., membranous nephropathy) can cause the syndrome in children, but this is uncommon.
Aetiology: ethnicity
Causes of nephrotic syndrome can also differ by ethnicity; for example, in a US study of adults with primary nephrotic syndrome, the most common cause of nephrotic syndrome in black patients was FSGS, whereas the most common causes in white and Asian patients were membranous nephropathy and MCD, respectively.[27]Mbakop C, DeVita MV, Wahl SJ, et al. Adult primary nephrotic syndrome trends by race: a diminished frequency of focal segmental glomerulosclerosis in non-black patients. Int Urol Nephrol. 2021 Apr;53(4):719-24.
http://www.ncbi.nlm.nih.gov/pubmed/33200335?tool=bestpractice.com
Conditions with features of nephrotic syndrome
Patients with IgA nephropathy, membranoproliferative glomerulonephritis (MPGN), and post-infectious glomerulonephritis may demonstrate some features of nephrotic syndrome (nephrotic range proteinuria with a low serum albumin). However, these causes of renal disease are predominantly nephritic and investigations will reveal haematuria, red cell casts, and possibly renal dysfunction.
Minimal change disease
MCD accounts for up to 90% of cases of nephrotic syndrome in children younger than 10 years.[28]Parikh RV, Tan TC, Fan D, et al. Population-based identification and temporal trend of children with primary nephrotic syndrome: the kaiser permanente nephrotic syndrome study. PLoS One. 2021 Oct 14;16(10):e0257674.
https://www.doi.org/10.1371/journal.pone.0257674
http://www.ncbi.nlm.nih.gov/pubmed/34648518?tool=bestpractice.com
[29]Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018 Nov;94(5):861-9.
http://www.ncbi.nlm.nih.gov/pubmed/29980292?tool=bestpractice.com
This figure decreases to approximately 50% in older children, and to between 10% and 20% in adults.[26]Jönsson A, Hellmark T, Segelmark M, et al. Causes of nephrotic syndrome in Sweden: the relevance of clinical presentation and demographics. Front Nephrol. 2023 Mar 17:3:1026864.
https://www.frontiersin.org/journals/nephrology/articles/10.3389/fneph.2023.1026864/full
http://www.ncbi.nlm.nih.gov/pubmed/37675382?tool=bestpractice.com
[28]Parikh RV, Tan TC, Fan D, et al. Population-based identification and temporal trend of children with primary nephrotic syndrome: the kaiser permanente nephrotic syndrome study. PLoS One. 2021 Oct 14;16(10):e0257674.
https://www.doi.org/10.1371/journal.pone.0257674
http://www.ncbi.nlm.nih.gov/pubmed/34648518?tool=bestpractice.com
[29]Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018 Nov;94(5):861-9.
http://www.ncbi.nlm.nih.gov/pubmed/29980292?tool=bestpractice.com
MCD is frequently classified as SRNS as there is often no histological diagnosis.
MCD is a major cause of idiopathic nephrotic syndrome.[30]Filler G, Young E, Geier P, et al. Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis. 2003 Dec;42(6):1107-13.
http://www.ncbi.nlm.nih.gov/pubmed/14655180?tool=bestpractice.com
[31]Vivarelli M, Massella L, Ruggiero B, et al. Minimal change disease. Clin J Am Soc Nephrol. 2017 Feb 7;12(2):332-45.
https://www.doi.org/10.2215/CJN.05000516
http://www.ncbi.nlm.nih.gov/pubmed/27940460?tool=bestpractice.com
In a minority of cases, it may be associated with an underlying secondary cause, such as non-steroidal anti-inflammatory drug (NSAID) use or Hodgkin's lymphoma.[32]Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006 Jun;69(12):2251-60.
https://www.doi.org/10.1038/sj.ki.5000341
http://www.ncbi.nlm.nih.gov/pubmed/16672913?tool=bestpractice.com
[33]Farruggia P, Trizzino A, Maringhini S, et al. Hodgkin lymphoma and nephrotic syndrome in childhood. Indian J Pediatr. 2010 Oct;77(10):1147-9.
http://www.ncbi.nlm.nih.gov/pubmed/20872097?tool=bestpractice.com
Infection is a recognised trigger in idiopathic nephrotic syndrome in children and adults.[34]Wenderfer SE. Viral-associated glomerulopathies in children. Pediatr Nephrol. 2015 Nov;30(11):1929-38.
https://www.doi.org/10.1007/s00467-015-3057-y
http://www.ncbi.nlm.nih.gov/pubmed/25752759?tool=bestpractice.com
In 20% to 30% of patients with MCD, there may be an associated acute kidney injury.[29]Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018 Nov;94(5):861-9.
http://www.ncbi.nlm.nih.gov/pubmed/29980292?tool=bestpractice.com
Risk factors for the development of acute kidney injury in patients with MCD include male sex, age >50 years, severe nephrotic syndrome, known hypertension, and arteriosclerosis.[29]Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018 Nov;94(5):861-9.
http://www.ncbi.nlm.nih.gov/pubmed/29980292?tool=bestpractice.com
'Minimal change' refers to light microscopic findings that often reveal normal glomeruli, or mild mesangial proliferation with negative immunofluorescence and no immune complex deposition. Electron microscopy, however, classically demonstrates diffuse effacement of the epithelial cell foot processes. MCD is typically responsive to steroids. If steroid resistance is noted, alternative aetiologies should be considered, in particular FSGS.
Focal segmental glomerulosclerosis
FSGS can be either primary (idiopathic), secondary, or genetic. Differentiating between primary and secondary FSGS is key in determining management, as primary FSGS may respond to immunosuppression, while secondary causes are treated by reducing intraglomerular pressure (renin-angiotensin blockade).
Secondary causes of FSGS can be divided into those caused by:[24]Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol. 2003 Mar;23(2):172-82.
http://www.ncbi.nlm.nih.gov/pubmed/12704577?tool=bestpractice.com
[25]Deegens JK, Wetzels JF. Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs Aging. 2007;24(9):717-32.
http://www.ncbi.nlm.nih.gov/pubmed/17727303?tool=bestpractice.com
[35]De Vriese AS, Sethi S, Nath KA, et al. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach. J Am Soc Nephrol. 2018 Mar;29(3):759-74.
https://www.doi.org/10.1681/ASN.2017090958
http://www.ncbi.nlm.nih.gov/pubmed/29321142?tool=bestpractice.com
[36]de Roij van Zuijdewijn C, van Dorp W, Florquin S, et al. Bisphosphonate nephropathy: a case series and review of the literature. Br J Clin Pharmacol. 2021 Sep;87(9):3485-91.
https://www.doi.org/10.1111/bcp.14780
http://www.ncbi.nlm.nih.gov/pubmed/33595131?tool=bestpractice.com
conditions such as HIV infection, reflux nephropathy, class III obesity (BMI 40 or above), chronic glomerular hyperfiltration from a solitary kidney, or any other cause of extensive nephron loss (e.g., renal obstruction, prior glomerulonephritis), or
certain drugs (such as pamidronate or heroin).
HIV is associated with collapsing FSGS, characterised by collapse and sclerosis of the entire glomerular tuft (non-segmental).
Genetic forms of FSGS usually present in childhood. A mutation in one of four genes (NPHS1, NPHS2, LAMB2, WT1) accounts for up to 85% of cases of SRNS presenting by 3 months, and up to 66% presenting in the first year of life.[3]Sadowski CE, Lovric S, Ashraf S, et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015 Jun;26(6):1279-89.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4446877
http://www.ncbi.nlm.nih.gov/pubmed/25349199?tool=bestpractice.com
[37]Hinkes BG, Mucha B, Vlangos CN, et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics. 2007 Apr;119(4):e907-19.
http://www.ncbi.nlm.nih.gov/pubmed/17371932?tool=bestpractice.com
Genetic analysis may be offered when FSGS cannot be classified by clinicopathological assessment.[35]De Vriese AS, Sethi S, Nath KA, et al. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach. J Am Soc Nephrol. 2018 Mar;29(3):759-74.
https://www.doi.org/10.1681/ASN.2017090958
http://www.ncbi.nlm.nih.gov/pubmed/29321142?tool=bestpractice.com
This is particularly relevant in young adult patients, especially when there is a strong family history. One cohort study demonstrated that a single-gene cause of SRNS was found in 29.5% of patients presenting before the age of 25.[3]Sadowski CE, Lovric S, Ashraf S, et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015 Jun;26(6):1279-89.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4446877
http://www.ncbi.nlm.nih.gov/pubmed/25349199?tool=bestpractice.com
FSGS commonly presents with haematuria, hypertension, and reduced renal function. Oedema may be present. Light microscopy shows segmental areas of mesangial collapse and sclerosis affecting some but not all glomeruli (focal disease). Patients are often resistant to steroids and renal biopsy is required to confirm diagnosis.
Membranous nephropathy
Membranous nephropathy is the most common cause of nephrotic syndrome in older adults but is rare in children.[23]Kolb A, Gallacher PJ, Campbell J, et al. A national registry study of patient and renal survival in adult nephrotic syndrome. Kidney Int Rep. 2021 Feb;6(2):449-59.
https://www.kireports.org/article/S2468-0249(20)31704-6/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/33615070?tool=bestpractice.com
[24]Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol. 2003 Mar;23(2):172-82.
http://www.ncbi.nlm.nih.gov/pubmed/12704577?tool=bestpractice.com
[25]Deegens JK, Wetzels JF. Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs Aging. 2007;24(9):717-32.
http://www.ncbi.nlm.nih.gov/pubmed/17727303?tool=bestpractice.com
[38]Nieto-Gañán I, Iturrieta-Zuazo I, Rita C, et al. Revisiting immunological and clinical aspects of membranous nephropathy. Clin Immunol. 2022 Apr;237:108976.
https://www.doi.org/10.1016/j.clim.2022.108976
http://www.ncbi.nlm.nih.gov/pubmed/35276323?tool=bestpractice.com
The majority of cases of membranous nephropathy are primary (70%), with the remaining 30% associated with malignancy, chronic infections (e.g., hepatitis B, hepatitis C, syphilis, malaria, or tuberculosis), autoimmune disease (e.g., lupus membranous nephropathy), or certain drugs (e.g., gold, penicillamine, and NSAIDs).[25]Deegens JK, Wetzels JF. Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs Aging. 2007;24(9):717-32.
http://www.ncbi.nlm.nih.gov/pubmed/17727303?tool=bestpractice.com
[39]Glassock RJ. Secondary membranous glomerulonephritis. Nephrol Dial Transplant. 1992;7(suppl 1):64-71.
http://www.ncbi.nlm.nih.gov/pubmed/1337185?tool=bestpractice.com
Primary membranous nephropathy
In primary membranous nephropathy, antibodies to M-type phospholipase A2 receptor (PLA2R) have been identified in 70% to 80% of patients.[40]Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009 Jul 2;361(1):11-21.
https://www.doi.org/10.1056/NEJMoa0810457
http://www.ncbi.nlm.nih.gov/pubmed/19571279?tool=bestpractice.com
[41]Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med. 2011 Feb 17;364(7):689-90.
http://www.nejm.org/doi/full/10.1056/NEJMc1011678
http://www.ncbi.nlm.nih.gov/pubmed/21323563?tool=bestpractice.com
Measurement of anti-PLA2R antibody titre is routine, contributing to diagnosis, treatment planning, and prognosis.[42]Ruggenenti P, Debiec H, Ruggiero B, et al. Anti-ohospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol. 2015 Oct;26(10):2545-58.
https://www.doi.org/10.1681/ASN.2014070640
http://www.ncbi.nlm.nih.gov/pubmed/25804280?tool=bestpractice.com
[43]Kim YG, Choi YW, Kim SY, et al. Anti-phospholipase A2 receptor antibody as prognostic indicator in idiopathic membranous nephropathy. Am J Nephrol. 2015;42(3):250-7.
http://www.ncbi.nlm.nih.gov/pubmed/26484659?tool=bestpractice.com
A negative anti-PLA2R antibody test (in the context of negative staining of the antigen, PLA2R, by immunohistochemistry in a renal biopsy) should provoke investigations for a secondary cause.
Microscopy demonstrates basement membrane thickening without associated cellular proliferation or infiltration in primary membranous nephropathy. Immunofluorescence reveals diffuse, granular IgG deposition throughout the capillary walls and electron microscopy shows electron dense deposits in the subepithelial space. New basement membrane growth between subepithelial immune deposits leads to the classic "spike and dome" appearance.
Secondary membranous nephropathy
The most common secondary cause of membranous nephropathy is malignancy. While this should be suspected in patients who present aged >60 years, subsequent investigations for underlying malignancy are determined on a case-by-case basis. A chest x-ray and a breast examination are reasonable, with other investigations (e.g., computed tomography chest, colonoscopy, mammography) guided by the symptoms.
Diabetic nephropathy
The most common cause of nephrotic syndrome in adults with long-standing diabetes. About 20% to 50% of patients with type 1 or type 2 diabetes develop evidence of diabetic nephropathy.[44]Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020 Apr;22 Suppl 1:3-15.
https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.14007
http://www.ncbi.nlm.nih.gov/pubmed/32267079?tool=bestpractice.com
[45]Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl (2011). 2018 Jan;8(1):2-7.
https://www.kisupplements.org/article/S2157-1716(17)30060-6/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/30675433?tool=bestpractice.com
[46]Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes. Diabetes Care. 2004 Jan;27(suppl 1):S79-83.
https://www.doi.org/10.2337/diacare.27.2007.s79
http://www.ncbi.nlm.nih.gov/pubmed/14693934?tool=bestpractice.com
Non-diabetic renal disease is also common in adults with diabetes.[47]Zeng YQ, Yang YX, Guan CJ, et al. Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021. BMC Endocr Disord. 2022 Jun 30;22(1):168.
https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-022-01082-8
http://www.ncbi.nlm.nih.gov/pubmed/35773653?tool=bestpractice.com
[48]Pham TT, Sim JJ, Kujubu DA, et al. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol. 2007;27(3):322-8.
http://www.ncbi.nlm.nih.gov/pubmed/17495429?tool=bestpractice.com
Microalbuminuria (≥30 mg/day) constitutes early clinical evidence of diabetic nephropathy. Left untreated, persistent microalbuminuria will progress to frank proteinuria in a proportion of patients over the subsequent 10 to 15 years.[49]García-Carro C, Vergara A, Bermejo S, et al. How to assess diabetic kidney disease progression? from albuminuria to GFR. J Clin Med. 2021 Jun 5;10(11):2025.
https://www.mdpi.com/2077-0383/10/11/2505
http://www.ncbi.nlm.nih.gov/pubmed/34198818?tool=bestpractice.com
[50]Correa-Rotter R, Naicker S, Katz IJ, et al. Demographic and epidemiologic transition in the developing world: role of albuminuria in the early diagnosis and prevention of renal and cardiovascular disease. Kidney Int Suppl. 2004 Nov;(92):S32-7.
http://www.ncbi.nlm.nih.gov/pubmed/15485413?tool=bestpractice.com
These patients are at risk of progressing to end-stage renal disease.
Patients with non-proteinuric diabetic kidney disease, such as hypertensive glomerulosclerosis or tubulointerstitial disease, are also at risk of decline in renal function.[51]Hobeika L, Hunt KJ, Neely BA, et al. Comparison of the rate of renal function decline in nonproteinuric patients with and without diabetes. Am J Med Sci. 2015 Dec;350(6):447-52.
http://www.ncbi.nlm.nih.gov/pubmed/26624901?tool=bestpractice.com
[52]Piccoli GB, Grassi G, Cabiddu G, et al. Diabetic kidney disease: a syndrome rather than a single disease. Rev Diabet Stud. 2015 Spring-Summer;12(1-2):87-109.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5397985
http://www.ncbi.nlm.nih.gov/pubmed/26676663?tool=bestpractice.com
A combination of pathogenic processes occurs including glomerular hyperfiltration, hyperglycaemia, and glycation of matrix proteins. Rarely, heavy proteinuria caused by diabetic nephropathy can lead to nephrotic syndrome. Diabetic nephropathy is defined by characteristic mesangial expansion, glomerular basement membrane thickening, and glomerular sclerosis leading to the development of Kimmelstiel-Wilson nodules.
Sudden development of heavy proteinuria in patients with diabetes is not typical and may suggest an alternative underlying diagnosis. Microscopic haematuria may be present in diabetic nephropathy, but in a patient presenting with haematuria, proteinuria, and a rapid decline in renal function, an alternative diagnosis must be considered. Absence of diabetic retinopathy should also suggest an alternative diagnosis.
Amyloidosis
Amyloidosis is responsible for around 10% of nephrotic syndrome cases. The main subtypes of amyloidosis include:[53]Real de Asúa D, Costa R, Galván JM, et al. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol. 2014 Oct 29:6:369-77.
https://www.doi.org/10.2147/CLEP.S39981
http://www.ncbi.nlm.nih.gov/pubmed/25378951?tool=bestpractice.com
[54]Ando Y, Coelho T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013 Feb 20;8:31.
https://www.doi.org/10.1186/1750-1172-8-31
http://www.ncbi.nlm.nih.gov/pubmed/23425518?tool=bestpractice.com
AA amyloid, which is associated with chronic inflammation (e.g., rheumatoid arthritis, inflammatory bowel disease) and chronic infections; usually affects the kidneys
Hereditary amyloidosis, usually caused by transthyretin amyloidosis; a multi-symptom disease that most commonly presents with a neuropathy, but can cause nephropathy, gastrointestinal impairment, cardiomyopathy, or ocular deposition.
Investigations should search for the presence of a monoclonal paraprotein in the urine or plasma.
Membranoproliferative glomerulonephritis
MPGN is a relatively rare cause of nephrotic syndrome and occurs primarily in children and young adults.[55]Scottish Paediatric Renal and Urology Network. Idiopathic nephrotic syndrome in children, management. Mar 2017 [internet publication].
http://www.sprun.scot.nhs.uk/professionals/guidelines
A pathophysiological classification has been proposed that splits MPGN into two major groups:[56]Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol. 2011 Jul;31(4):341-8.
http://www.ncbi.nlm.nih.gov/pubmed/21839367?tool=bestpractice.com
[57]Salvadori M, Rosso G. Reclassification of membranoproliferative glomerulonephritis: identification of a new GN: C3GN. World J Nephrol. 2016 Jul 6;5(4):308-20.
https://www.wjgnet.com/2220-6124/full/v5/i4/308.htm
http://www.ncbi.nlm.nih.gov/pubmed/27458560?tool=bestpractice.com
Presence of immunoglobulins with or without C3: differentials include monoclonal gammopathy of renal significance, autoimmune diseases (mixed cryoglobulinaemia), and infections (hepatitis B and C, chronic bacterial infections), or
C3 staining without immunoglobulin deposition: C3 glomerulopathies such as C3GN or dense deposit disease (DDD). Both C3GN and DDD require investigation for genetic disorders of complement regulation.
Malignant hypertension
A rare cause of nephrotic syndrome; can be diagnosed on the basis of the blood pressure and, usually, fundoscopic signs. However, a presentation with proteinuria and raised blood pressure may be part of a nephritic syndrome, typically seen with acute glomerulonephritis, in which case there will be microscopic haematuria and red cell casts on urine microscopy.
Congenital nephrotic syndrome
Congenital nephrotic syndrome presents at birth or in the first 3 months of life. Infantile nephrotic syndrome presents between 3 and 12 months. The majority of children will have an underlying genetic cause of disease, be unresponsive to immunosuppression, and have a poor prognosis with respect to progression to end-stage renal disease.[37]Hinkes BG, Mucha B, Vlangos CN, et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics. 2007 Apr;119(4):e907-19.
http://www.ncbi.nlm.nih.gov/pubmed/17371932?tool=bestpractice.com
[58]Boyer O, Schaefer F, Haffner D, et al. Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group. Nat Rev Nephrol. 2021 Apr;17(4):277-89.
https://www.doi.org/10.1038/s41581-020-00384-1
http://www.ncbi.nlm.nih.gov/pubmed/33514942?tool=bestpractice.com
Other causes of nephrotic syndrome
Uncommon causes of nephrotic syndrome include fibrillary glomerulopathies (e.g., fibrillary glomerulopathy and immunotactoid glomerulopathy), multiple myeloma (light-chain deposition diseases), Fabry's disease, nail-patella syndrome, and Alport syndrome.